Regular readers know that I have frequently blogged on the topic of Gardasil, Merck's HPV vaccine.
The New York Times today (August 20, 2008) published an in-depth article examining the manner in which Merck has marketed the drug and the controversies surrounding Merck's efforts. Merck calls the efforts "education," but critics call it marketing. This article is certainly worth reading by all parents of teenage girls. The New York Times article can be accessed here. Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise
My Blog article "Human papillomavirus (HPV) is more prevalent than we thought" provides statistics and links to my other collected writings on the topic of Gardasil.
For further reading, The Evidence Gap is a the New York Times' series that explores medical treatments in use despite scant proof they work and discusses steps toward more consistent use of evidence-based medicine.